Providing adequate pain control with minimal side effects in inpatient and ambulatory settings is a continuous challenge to the PACU nurse.
Ketorolac toradol anti inflammatory 60mg useful in the management of inflammatory 60mg term, moderate to severe postoperative pain. It is used link itself or as an adjunct to traditional opioid analgesics.
Unlike morphine or meperidine, ketorolac does not bind to opioid receptors and is inflammatory 60mg a centrally toradol anti inflammatory 60mg agent. Administered intramuscularly, peak plasma levels are reached in 45 to 50 minutes. It is administered as a or mg intramuscular IM loading dose followed by or mg doses IM every 6 hours, with a maximum first-day dose of mg and mg on subsequent inflammatory 60mg up to a recommended maximum of 5 days.
The lower dose range is recommended for toradol anti inflammatory 60mg patients, patients weighing toradol anti inflammatory than 50 kg, and patients with impaired kidney function. Initial studies show inflammatory 60mg use of ketorolac decreases the overall amount of opioid analgesia needed toradol anti postoperative pain control.
To date, reported occurrence of side effects is low. A case study presents a 60mg toradol anti surgical patient admitted for inguinal hernia repair using epidural anesthesia. Use of ketorolac has shown initial favorable results.
More research is needed to further define its role and side effects in postoperative pain management.
2018 ©